> Home
 

 

Oscillococcinum® 

Nature's #1 Flu Medicine™

For relief of symptoms of flu such as fever, chills, body aches and pains.

Take Oscillococcinum at the First Sign of Flu. Non-drowsy, no drug interactions Oscillococcinum (o-sill-o-cox-see-num) is safe, natural and easy to take. Oscillococcinum works best when taken at the first sign of flu.  So make sure you have some on hand to
fend off your flu symptoms at their onset. Used by millions of people in 43 countries The First Thing to Take at the First Sign of Flu™

Oscillococcinum Advantages: 

  • No drowsiness or stimulant effect. 
  • Safe for the elderly and those at high risk when exposed to seasonal flu. 
  • Safe for use if you are currently on prescription medication. 
  • Safe for use if you have any of the following diseases: cardiovascular disease, prostate disease, hypertension, glaucoma, thyroid disease. 
  • Safe for use by occupations that prohibits the use of traditional OTC flu remedies such as truck drivers, machine operators, pilots, etc... 
  • Safe for use for people with kidney or liver disorders. 
  • Can be used with caution in diabetics.

Active Ingredients

Anas barbariae hepatis et cordis extractum 200CK

3 Doses Oscillococcinum  - Our Price $5.99 Suggested Retail $8.25

6 Doses Oscillococcinum - Our Price $10.99 Suggested Retail $14.29

Clinical Research:

A double-blind, placebo-controlled pilot study of 100 patients showed that, when given at the onset of influenza-like symptoms, Oscillococcinum worked better than the placebo in reducing the symptoms of chills (85.7% vs. 57.1%), stiffness (72.5% vs. 41.9%) and fever (79.1% vs. 40%). Also 80% of patients given Oscillococcinum’ reported the treatment to be a success vs. 38% in the placebo group.

In a double-blind, clinical trial of 300 patients with influenza-like symptoms, 55% of the patients taking Oscillococcinum’ reported no chills after four days, compared with 27% of the placebo- controlled group. More patients in the Oscillo’ group also reported no aches after four days-70% were ache-free compared with 48% in the placebo group. Fever in the Oscillococcinum’ group was significantly lower starting on the I second day of the treatment, compared to the placebo group.

In a double-blind, clinical trial of 478 patients published in The British Journal of Clinical Pharmacology in 1989, researchers studied Oscillococcinum’s effect on nine influenza-like symptoms-fever, headaches, stiffness, lumbar and particular pain, shivers, cough, coryza and fatigue - versus a placebo.  The proportion of patients who recovered within 48 hours of treatment was significantly superior among the Oscillo group than the placebo group.

A recent double-blind, clinical trial of 372 patients performed by f researchers at a German University and published in April 1998 yielded results similar to those published in the British Journal of Clinical Pharmacology (above). The complete disappearance of symptoms after 48 hours  was significantly superior among the Oscillo group than among the placebo group. This clinical trial also showed that treatment of influenza-like symptoms with Oscillococcinum’ has positive effect on the decline of symptoms and on the duration of the disease.